Updated Jul 16, 2026
Newcomer Lee Nisley has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Based on the 2026-06-05 SEC filing, Newcomer Lee Nisley is a director of Myriad Genetics, Inc. Public biographical information about this individual is limited beyond the stated board role. The name may appear in filings with variations (for example, as 'Lee Nisley Newcomer' or 'Lee N. Nisley'), and there is no readily verifiable information in widely accessible sources about education, prior positions, or other board memberships. If this is a naming collision or a differently named individual, please provide additional identifiers to confirm.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | CHRS | Coherus BioSciences, Inc. | A — Grant or award | 30.0K | $0.00 | |
| 2026-06-05 | MYGN | MYRIAD GENETICS INC | A — Grant or award | 59.7K | $0.00 |
Based on the 2026-06-05 SEC filing, Newcomer Lee Nisley is a director of Myriad Genetics, Inc. Public biographical information about this individual is limited beyond the stated board role. The name may appear in filings with variations (for example, as 'Lee Nisley Newcomer' or 'Lee N. Nisley'), and there is no readily verifiable information in widely accessible sources about e…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Newcomer Lee Nisley profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.